"Medolife Rx Schedules Investor Webcast For Tuesday, July 27, 2021 GlobeNewswire - 2 minutes ago via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTCPINK:QNTA), announced today that it will hold a webcast and Q&A with the investment community on Tuesday, July 27, at 5 p.m. Eastern Daylight Time. The purpose of this is to answer questions received from the investment community all at one time in an open forum.
On the webcast, Medolife CEO Dr. Arthur Mikaelian and additional members of the Medolife team will discuss recent happenings within the Company, including the following:
-- Social media - i.e., Twitter etc.
-- Update on Investor Relations team
-- Aelia Store
-- Authorized share overview
-- Reverse split overview
-- Nasdaq update
-- Name change and ticker symbol
-- Tony Hawk updates
-- Sports opportunities update
-- Escozine(R) certification of registration number in Dominican Republic
-- Mexico partnership update
-- Opportunities in Vietnam, Cambodia, Colombia
-- US FDA Update
-- Dilution / Reg A / Convertible notes
-- Video being developed
-- Polarization technology can revolutionize the pharmaceutical business with R&D when it comes to venoms of all kinds and other dangerous material
To register for this webcast, please use the below web link.
If you have questions, please email medolife@cmwmedia.comwith "QNTA Question" in the subject line by 6 p.m. Eastern Daylight Time on Monday, July 26, to ensure all issues are addressed, but there will be a live Q&A also. Dr. Mikaelian will answer as many questions as time will allow. For those unable to participate in the live webcast, an archived version of the webcast will be available in the following days.
END QUOTE !!
THAT = we're about to be SHOWN THE ENTIRE PLAN by the new QNTA aka MedoLifeRx by the time this conference takes place IMO !!
NEW TICKER and NEW COMPANY NAME - as they openly CALLED THEMSELVES "MedoLife Rx" ALREADY for the upcoming conference call/open discussion WITH INVESTORS, FULLY PUBLIC ACCESS :)
Market Data 
Markets 
AI
